NCT00088387View on ClinicalTrials.gov

Effect of Lithium and Divalproex in Alzheimer's Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 31, 2004

Study Completion Date

March 31, 2005

Conditions
Alzheimer Disease
Interventions
DRUG

Divalproex

DRUG

Lithium

Trial Locations (1)

20892

National Institute of Neurological Disorders and Stroke (NINDS), Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00088387 - Effect of Lithium and Divalproex in Alzheimer's Disease | Biotech Hunter | Biotech Hunter